TRIM27 anticorps (full length)

N° du produit ABIN7879208

Cet anticorps Souris Monoclonal détecte spécifiquement TRIM27 dans IF et FACS. Il présente une réactivité avec des échantillons de Humain.

Aperçu rapide pour TRIM27 anticorps (full length) (ABIN7879208)

Antigène: TRIM27 (Tripartite Motif Containing 27 (TRIM27))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp TRIM27 est non-conjugé

Application: Immunofluorescence (IF), Flow Cytometry (FACS)

Clone: PCRP-TRIM27-1B3

Détail du produit anti-TRIM27 anticorps

Épitope: full length

Fonction: TRIM27 Antibody

Purification: Protein A/G affinity

Immunogène: Recombinant full-length human TRIM27 protein was used as the immunogen for the TRIM27 antibody.

Isotype: IgG2a

Information d'application

Indications d'application: Optimal dilution of the TRIM27 antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.2 mg/mL

Buffer: 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced), 0.05 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Aliquot the TRIM27 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur TRIM27

Antigène: TRIM27 (Tripartite Motif Containing 27 (TRIM27))

Autre désignation: TRIM27

Sujet: Defects in TRIM27 are a cause of thyroid papillary carcinoma (TPC). TPC is a common tumor of the thyroid that typically arises as an irregular, solid or cystic mass from otherwise normal thyroid tissue. Papillary carcinomas are malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells.

UniProt: P14373